News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website


Data On the Use of Interferon Alfa-n3 in the Treatment of Multiple Sclerosis Presented At the XVII World Congress of Neurology Meeting (Business Wire)Interferon Sciences, Inc. announced that a poster reporting on a retrospective evaluation entitled, ~~~Interferon alfa-n3 Reduces Enhancing Gadolinium Brain Lesions in Multiple Sclerosis~~~ was presented at the XVII World Congress of Neurology Meeting in London, by Professor William Sheremata, Chief of the Multiple Sclerosis/Neuroimmunology Center of the University of Miami School of Medicine.- Jun 25 9:17 AM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557